Exaggerated molecular response to injections of interferon-β predicts disease activity in multiple sclerosis

被引:0
|
作者
Rudick, Richard A.
Rani, M. R. Sandhya
Xu, Yaomin
Lee, Jar-Chi
Na, Jie
Shrock, Jennifer
Josyula, Anupama
Fisher, Elizabeth
Ransohoff, Richard M.
机构
关键词
D O I
10.1016/j.cyto.2010.07.421
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:100 / 100
页数:1
相关论文
共 50 条
  • [31] Pharmacokinetic considerations in the treatment of multiple sclerosis with interferon-β
    Hegen, Harald
    Auer, Michael
    Deisenhammer, Florian
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (12) : 1803 - 1819
  • [32] Production of endogenous interferon-α and β in patients with multiple sclerosis
    Wandinger, KP
    Reissland, P
    Kirchner, H
    Wessel, K
    Otto, M
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (02): : 277 - 278
  • [33] The Mechanism of Action of Interferon-β in Relapsing Multiple Sclerosis
    Bernd C. Kieseier
    CNS Drugs, 2011, 25 : 491 - 502
  • [34] Trial of interferon-β in multiple sclerosis stopped early
    Bonn, D
    LANCET, 1998, 351 (9102): : 573 - 573
  • [35] Psychiatric side effects of interferon-β in multiple sclerosis
    Goeb, JL
    Even, C
    Nicolas, G
    Gohier, B
    Dubas, F
    Garré, JB
    EUROPEAN PSYCHIATRY, 2006, 21 (03) : 186 - 193
  • [36] Interferon-β therapy for multiple sclerosis is linked with headache
    Nature Clinical Practice Neurology, 2006, 2 (10): : 520 - 521
  • [37] Immmunomodulation by quercetin and interferon-β in multiple sclerosis patients
    Chadha, Kailash
    Sternberg, Zohara
    Lieberman, Alicia
    Drake, Allison
    Weinstock-Guttman, Bianca
    Munschauer, Frederick
    CYTOKINE, 2009, 48 (1-2) : 108 - 108
  • [38] Migraines linked to interferon-β treatment of multiple sclerosis
    Khromov, A
    Segal, M
    Nissinoff, J
    Fast, A
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2005, 84 (08) : 644 - 647
  • [39] Pharmacogenetic study of long-term response to interferon-β treatment in multiple sclerosis
    Clarelli, F.
    Liberatore, G.
    Sorosina, M.
    Osiceanu, A. M.
    Esposito, F.
    Mascia, E.
    Santoro, S.
    Pavan, G.
    Colombo, B.
    Moiola, L.
    Martinelli, V.
    Comi, G.
    Martinelli-Boneschi, F.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (01): : 84 - 91
  • [40] Pharmacogenetic study of long-term response to interferon-β treatment in multiple sclerosis
    F Clarelli
    G Liberatore
    M Sorosina
    A M Osiceanu
    F Esposito
    E Mascia
    S Santoro
    G Pavan
    B Colombo
    L Moiola
    V Martinelli
    G Comi
    F Martinelli-Boneschi
    The Pharmacogenomics Journal, 2017, 17 : 84 - 91